Transocean (RIG) upgraded at Argus from Hold to Buy, Argus said. $62 price target. Company has made several smart strategic decisions.
Rosetta Resources (ROSE) upgraded at Citigroup to Buy from Neutral, Citigroup said. $60 price target. Solid Q3 beat and 2013 guidance.
Seattle Genetics (SGEN) downgraded at Cantor from Hold to Sell, Cantor FItzgerald said. $20 price target. Adcetris is growing slower than expected.
STOCK COMMENTS / EPS CHANGESAccretive Health (AH) numbers lowered at Oppenheimer Shares of AH now seen reaching $15, Oppenheimer said. Estimates also lowered on 3Q results. Outperform rating.
Auxilium Pharma (AUXL) numbers lowered at Jefferies. Shares of AUXL now seen reaching $29, Jefferies said. Estimates also lowered on Testim miss. Buy rating.Cablevision (CVC) estimates, target reduced at Morgan Stanley. Shares of CVC now seen reaching $15, according to Morgan Stanley. Estimates also cut, as the company is realizing lower margins. Underweight rating. HollyFrontier (HFC) numbers increased at Credit Suisse. HFC estimates were raised through 2015, Credit Suisse said. Company is seeing higher refining growth. Neutral rating and new $53 price target. Melco Crown (MPEL) numbers raised at Citigroup. Shares of MPEL now seen reaching $22.50, Citigroup said. Estimates also increased on Q3 beat. Buy rating. NYSE Euronext (NYX) numbers cut at Citigroup. Shares of NYX now seen reaching $25, Citigroup said. Estimates also lowered as environment remains challenging. Neutral rating. RealPage (RP) estimates, target reduced at Credit Suisse. Shares of RP now seen reaching $27, according to Credit Suisse. Estimates also cut, gvien product delays. Outperform rating. WellPoint (WLP) target raised at Jefferies. Shares of WLP now seen reaching $64, Jefferies said. Results show signs of stability. Hold rating. WellPoint numbers lowered at Oppenheimer. Shares of WLP now seen reaching $73, Oppenheimer said. Estimates also lowered on 3Q results. Outperform rating. Wellpoint estimates, target boosted at BMO. Shares of WLP now seen reaching $65, according to BMO Capital. Estimates also upped, as the company is keeping a tight lid on costs. >To submit a news tip, email: email@example.com.
Twitter and become a fan on Facebook.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV